Gsr-Dsr Capsule is a combination pharmaceutical formulation containing Domperidone 30 mg and Esomeprazole 40 mg, designed to manage gastrointestinal disorders characterized by acid-related symptoms and motility disturbances. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating associated with delayed gastric emptying or gastroparesis. Esomeprazole, a proton pump inhibitor (PPI), suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing effective relief from acid reflux, gastroesophageal reflux disease (GERD), and peptic ulcers. The synergistic action of these two agents makes Gsr-Dsr Capsule particularly useful in conditions where both acid suppression and enhanced gastric motility are required, such as in GERD with associated gastroparesis or functional dyspepsia. The medication should be administered as prescribed by a healthcare professional, typically before meals to optimize efficacy. Caution is advised in patients with known hypersensitivity to either component, underlying cardiac conditions, or hepatic impairment. Regular monitoring and adherence to prescribed dosage are essential to minimize potential side effects and ensure therapeutic effectiveness.